ADMA Biologics Inc (ADMA) — Cash Flow Quality Index
ADMA Biologics Inc (ADMA) has a Cash Flow Quality Index of 1.29x as of March 2026. Operating cash flow of $58.25 Million exceeds net income of $45.33 Million, indicating high earnings quality where cash backs reported profits. Also explore total assets of ADMA Biologics Inc for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ADMA Biologics Inc Cash Flow Quality Index (2024–2025)
Historical Cash Flow Quality Index for ADMA Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of ADMA Biologics Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ADMA Biologics Inc (2024–2025)
Year-by-year earnings quality comparison for ADMA Biologics Inc. For live market cap and the full company financial profile, see ADMA Biologics Inc (ADMA) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | $50.40 Million | $146.93 Million | ▼ -42.9% |
| 2024 | 0.60x | $118.67 Million | $197.67 Million | — |